Letters to the Editor

Novel KAT6B::NUTM2B fusion oncogene in congenital acute myeloid leukemia and implications for menin inhibitor therapy

Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN
Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN
Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN
Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN
Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN
Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN
Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN; Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai
Center of Excellence in Leukemia Studies, St. Jude Children’s Research Hospital, Memphis, TN
Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN
Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN
Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN
Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN
Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN
Department of Bone Marrow Transplant and Cellular Therapy, St. Jude Children’s Research Hospital, Memphis, TN
Department of Hematology/Oncology, St Jude Affiliate Clinic, Our Lady of the Lake Children's Hospital, Baton Rouge, LA
Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN
Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN
Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN
Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN
Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN
Haematologica Early view Apr 23, 2026 https://doi.org/10.3324/haematol.2025.300350